Humoral immunity to adeno-associated virus type 2 vectors following administration to murine and nonhuman primate muscle

Journal of Virology

Volumn 74, Issue 5, 2000, Pages 2420-2425

  Chirmule, Narendra ^a,b   Xiao, Weidong ^b   Truneh, Alemseged ^c   Schnell, Michael A ^a   Hughes, Joseph V ^a   Zoltick, Philip ^b   Wilson, James M ^a,b,d  

^a Institute for Human Gene Therapy   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c GLAXOSMITHKLINE   (United Kingdom)

^d WISTAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; CD4 ANTIGEN; NEUTRALIZING ANTIBODY;

ADENO ASSOCIATED VIRUS; ADOLESCENT; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; EXPRESSION VECTOR; GENE EXPRESSION; GENE TRANSFER; HUMORAL IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SKELETAL MUSCLE; T LYMPHOCYTE;

ANIMALS; ANTIBODIES; ANTIBODIES, VIRAL; ANTIGENS, CD4; CAPSID; CD4-POSITIVE T-LYMPHOCYTES; DEPENDOVIRUS; GENE THERAPY; GENETIC VECTORS; IMMUNOGLOBULIN ISOTYPES; INJECTIONS, INTRAMUSCULAR; MACACA MULATTA; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, NUDE; MICE, TRANSGENIC; PARVOVIRIDAE INFECTIONS; RECOMBINANT PROTEINS; TIME FACTORS;

EID: 0033977047     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.5.2420-2425.2000     Document Type: Article

References (19)

1. Abbas, A. K., K. M. Murphy, and A. Sher. 1996. Functional diversity of helper T lymphocytes. Nature 383:787-793.
2. Blau, H. M., and M. L. Springer. 1995. Muscle-mediated gene therapy. N. Engl. J. Med. 23:1554-1556.
3. Carter, B. J., and T. R. Flotte. 1996. Development of adeno-associated virus vectors for gene therapy of cystic fibrosis. Curr. Top. Microbiol. Immunol. 218:119-144.
4. Chirmule, N., J. V. Hughes, G.-P. Gao, S. E. Raper, and J. M. Wilson. 1998. Role of E4 in eliciting CD4 T-cell and B-cell responses to adenovirus vectors delivered to murine and nonhuman primate lungs. J. Virol. 72:6138-6145.
5. Chirmule, N., A. Truneh, S. E. Haecker, J. T. Tazelaar, G.-P. Gao, S. E. Raper, J. V. Hughes, and J. M. Wilson. 1999. Repeated administration of adenoviral vectors in lungs of human CD4 transgenic mice treated with a non-depleting antibody. J. Immunol. 163:448-455.
6. Fisher, K. J., K. J. Jooss, J. Alston, Y. Yang, S. E. Haecker, K. High, R. Pathak, S. E. Raper, and J. M. Wilson. 1997. Recombinant adeno-associated virus for muscle directed gene therapy. Nat. Med. 3:306-312.
7. Gao, G.-P., G. Qu, L. Faust, R. K. Engdahl, W. Xiao, J. V. Hughes, P. Zoltick, and J. M. Wilson. 1998. High-titer adeno-associated viral vectors from a rep/cap cell line and hybrid shuttle virus. Hum. Gene Ther. 9:2353-2362.
8. Halbert, C. L., T. A. Standaert, C. B. Wilson, and A. D. Miller. 1998. Successful readministration of adeno-associated virus vectors to the mouse lung requires transient immunosuppression during the initial exposure. J. Virol. 72:9795-9805.
9. Herzog, R. W., E. Y. Yang, L. B. Couto, J. N. Hagstrom, D. Elwell, P. A. Fielfs, M. Burton, D. A. Bellinger, M. S. Read, K. M. Brinkhouse, G. M. Podsakoff, T. C. Nichols, G. J. Kurtzman, and K. A. High. 1999. Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector. Nat. Med. 5:56-63.
10. Jooss, K., Y. Yang, K. J. Fisher, and J. M. Wilson. 1998. Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers. J. Virol. 72:4212-4223.
11. Manning, W. C., S. Zhou, M. P. Bland, J. A. Escobedo, and V. Dwarki. 1998. Transient immunosuppression allows transgene expression following read-ministration of adeno-associated viral vectors. Hum. Gene Ther. 9:477-485.
12. Rajewsky, K. 1996. Clonal selection and learning in the antibody system. Nature 381:751-758.
13. Sousa, C. R., S. Hieny, T. Scharton-Kersten, D. Jankovic, H. Charest, R. N. Germain, and A. Sher. 1997. In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas. J. Exp. Med. 186:1819-1829.
14. Synder, R. O., C. Niao, L. Meuse, J. Tubb, B. A. Donahue, H.-F. Lin, D. W. Stafford, S. Patel, A. R. Thompson, T. Nichols, M. S. Read, D. A. Bellinger, K. M. Brinkhous, and M. A. Kay. 1999. Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors. Nat. Med. 5:64-70.
15. Verma, I. M., and N. Somia. 1997. Gene therapy - promises, problems and prospects. Nature 389:239.
16. Xiao, W. D., N. Chirmule, S. Berta, B. McCullough, G.-P. Gao, and J. M. Wilson. 1999. Gene therapy vectors based on adeno-associated virus type I. J. Virol. 73:3994-4003.
17. Xiao, X., J. Li, and R. J. Samulski. 1996. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J. Virol. 70:8098-8108.
18. Ye, X., V. M. Rivera, P. Zoltick, F. Cerasoli, M. A. Schnell, P. P. Gao, J. V. Highes, M. Gilman, and J. M. Wilson. 1999. Regulated delivery of therapeutic proteins after in vivo somatic cell gene transfer. Science 283:88-91
19. . 19. Zhou, S., J. E. Murphy, J. A. Escobedo, and V. J. Dwarki. 1998. Adeno-associated virus-mediated delivery of erythropoietin leads to sustained elevation of hematocrit in nonhuman primates. Gene Ther. 5:665-670.